Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm
Authors:
- Aun Yeong ChongACAun Yeong Chong
- Bernard S.P. ChinBCBernard S.P. Chin
- Andrew D. BlannABAndrew D. Blann
- Gregory Y.H. LipGregory Y.H. Lip
- 31 December 2005
- journal article
- other
- Published by Elsevier in Thrombosis Research
- Vol. 116 (2) , 181-183
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical Trials Update and Cumulative Meta-Analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and Cardiac Resynchronisation Therapy in Heart FailureEuropean Journal of Heart Failure, 2004
- Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillationEuropean Heart Journal, 2003
- Decrease in fibrin content of venous thrombi in selectin-deficient miceJournal of Surgical Research, 2003
- Antiplatelets agents and anticoagulants for hypertension2001
- The LIDO, HOPE, MOXCON and WASH StudiesEuropean Journal of Heart Failure, 1999
- Relationship Between Prothrombin Activation Fragment F1.2 and International Normalized Ratio in Patients With Atrial FibrillationStroke, 1997
- Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery diseaseThrombosis Research, 1992
- Idiopathic dilated Cardiomyopathy: Analysis of 152 necropsy patientsThe American Journal of Cardiology, 1987
- The natural history of idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1981
- Idiopathic myocardial hypertrophy∗The American Journal of Cardiology, 1958